Evolus, Inc. (EOLS) intrinsic value & 10-year financials
Evolus, Inc. (EOLS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 42.9% a year to $297.2M, with an average return on invested capital of -95.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $7.10
- Market cap
- $457.7M
- Revenue (FY2025)
- $297.2M
- Revenue growth (10-yr CAGR)
- 42.9%
- ROIC (10-yr avg)
- -95.5%
- Free cash flow (FY2025)
- -$45.7M
EOLS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $297.2M | -$51.6M | -$0.80 | -$45.7M | -11.0% | -53.4% |
| FY2024 | $266.3M | -$50.4M | -$0.81 | -$19.5M | -12.9% | -77.8% |
| FY2023 | $202.1M | -$61.7M | -$1.08 | -$34.5M | -24.4% | -124.1% |
| FY2022 | $148.6M | -$74.4M | -$1.33 | -$86.5M | -44.0% | -279.3% |
| FY2021 | $99.7M | -$46.8M | -$0.94 | -$33.8M | -44.6% | 54.4% |
| FY2020 | $56.5M | -$163.0M | -$4.83 | -$58.7M | -270.7% | 244.1% |
| FY2019 | $34.9M | -$90.0M | — | -$93.7M | -283.3% | -444.1% |
| FY2018 | $0 | -$46.9M | — | -$25.7M | — | -169.7% |
| FY2017 | — | -$4.5M | — | — | — | -9.3% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Evolus, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Evolus, Inc. has historically struggled to out-earn its cost of capital, averaging just -24.1% ROIC.
Evolus, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Evolus, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-26.57 per share.